Revalesio

Revalesio is a clinical-stage pharmaceutical company with a vision to change the future of treatment for people with neurological diseases through the development of effective and well tolerated medicines. The company's pioneering nanotechnology addresses fundamental disease mechanisms, such as mitochondrial dysfunction and inflammation, to provide neuroprotection and thereby slow disease progression and improve quality of life.